diabetes, obesity & metabolism research in the early 21 st century* (*from the nih point of...
DESCRIPTION
Diabetes, Obesity & Metabolism Research in the Early 21 st Century* (*from the NIH Point of View). December, 2004 Maren R. Laughlin, Ph.D. Senior Advisor for Integrative Metabolism National Institute of Diabetes & Digestive and Kidney Diseases National Institutes of Health. - PowerPoint PPT PresentationTRANSCRIPT
Diabetes, Obesity & Metabolism Research in the Early 21st Century* (*from the NIH Point of View)
December, 2004
Maren R. Laughlin, Ph.D.Senior Advisor for Integrative
MetabolismNational Institute of Diabetes & Digestive and Kidney Diseases
National Institutes of Health
Three Major Areas of Interest Diabetes & Metabolic Disease
NIDDK, NHLBI, NIA, NICHD, NIAID, NCI, NIBIB, etc.
ObesityTrans-NIH
http://www.obesityresearch.nih.gov/
http://www.niddk.nih.gov/welcome/org/OD/OOR/OOR.htm
NIH RoadmapTrans-NIH
www.nihroadmap.nih.gov
Diabetes & Metabolic Disease* (*from the NIH Point of View)Type 2 Diabetes Incidence: ~18M Americans Healthcare burden: $132B in 2002 Recently found in children and young people as well as older
adults Major focus of NIDDK research efforts
Type 1 DiabetesSpecial Statutory Funding Program for Type 1 Diabetes Research http://www.niddk.nih.gov/fund/diabetesspecialfunds/funding.htm
$1.14 billion for FY 1998 - FY 2008
Diabetic Complications Common to type 1 and type 2 diabetes Heart disease/atherosclerosis, microvascular disease /
neuropathy, retinopathy, nephropathy
Multi-pronged Approach to Diabetes Research
Investigator Initiated Grants Treatment and Prevention Trials Epidemiology Genetics studies Requests for Applications: NIH Initiated Grants Resources, such as
Animal models Tissue sources Standards Reagents and technologies
Community Organization (consortia, collaberations, workshops, etc)
Training
Type 2 Diabetes Resources
Diabetes Centers: DERCs and DTRCsProvides core resources to foster interdisciplinary research in diabetes and related areas
International Type 2 Diabetes Linkage Analysis Consortium
Mouse Metabolic Phenotyping Centers (MMPC)
Mice are shipped to a Center for in-depth phenotyping
Nuclear Receptor Signaling Atlasto gather and organize information relating to key aspects of
orphan nuclear receptor biology
Type 1 Diabetes Resources cont’d.
Islet Cell Resource Centers (ICR) Human Pancreatic Islets Available for Non-Clinical Research ($0.10 / islet)
Availability of pancreas-specific microarraysMouse PancChip 5.0 and Human PancChip 1.0
Beta Cell Biology ConsortiumReagents for study of islet development & cell replacement therapies
Type 1 Diabetes Resources
Collaborative Projects on Proteomics & Metabolomics For Type 1 Diabetes & its ComplicationsClearinghouse for tissue samples for proteomics/metabolomics analysis www.niddk.nih.gov/fund/diabetesspecialfunds/proteomics/
Access to samples from major clinical trials (DCCT, DPP)
Type 1 Diabetes-Rapid Access to Intervention Development (T1D-RAID)Resources to aid in pre-clinical development of new drugs
Type 1 Diabetes Mouse Repository at the Jax Labs
Animal Models of Diabetic Complications ConsortiumMice and pig models
Growth in Basic Biology Programs
Beta cell developmental biology:
(stem cells and transcription factors, toward cell therapy)
Islet transplantation and engineering
Imaging the pancreatic beta cell
Adipocyte as endocrine organ
Immunology of diabetes
Mechanisms of insulin resistance
Neurobiology of energy balance
Proteomics and metabolomics of diabetes:
Biomarkers of disease
Diabetic Complications
Hypoglycemia unawareness
Molecular mechanisms
Current & Future Diabetes Initiatives
Current:RFA-DK-04-022 receipt: March 17, 2005Collaborative Studies on Angiogenesis and Diabetic
Complications
RFA-DK-05-001 receipt: February 24, 2005 Preventing Mitochondrial Oxidative Stress in Diabetes and
Obesity
Coming Soon: Beta Cell Regeneration for Diabetes Therapy (RFA) Pilot and Feasibility Program in Human Islet Biology (RFA) Mouse Metabolic Phenotyping Centers (RFA)
Special Emphasis Program Announcements PA-04-092 Long-Term Weight Maintenance: Basic and Clinical Studies
PA-04-088 Non-Invasive Methods for Diagnosis and Progression of Diabetes, Kidney, Urological, Hematological , and Digestive Diseases
PA-04-081 Proteomics: Diabetes, Obesity, and Endocrine, Digestive, Kidney, Urologic, and Hematologic Diseases
PAR-04-078 Ancillary Studies to Major Ongoing NIDDK Clinical Research Studies PA-04-074 Health Disparities in NIDDK Diseases
PA-04-068 Development Assays for High Throughput Drug Screening
PA 04-033 Diet Composition and Energy Balance
Diabetes Program Announcements
PA 03-052 Proteomics in Diabetes and Other Endocrine and Metabolic Diseases
PA 02-077 Secondary Analyses in Diabetes, Digestive and Kidney Diseases
PA03-0156 Insulin Signaling and Receptor Cross-Talk
PA-04-033 Diet Composition and Energy Balance
PA-04-098 Heterogeneity of Fat Depots: Underlying Basis and Association with Morbidity
PA 03-150 Erythroid Lineage Molecular Toolbox
PA 03-145 Ubiquitin and Ubiquitin-Like Modification Regulating Disease Processes PA 02-161 Development of the Endocrine Pancreas
PA 02-117 Racial & Ethnic Differences in the Etiology of Type 2 Diabetes in United States
PA 01-117 Liver and Pancreatic Disease in HIV Infection
PA 01-112 The Role of Antioxidants in the Prevention of Diabetic Complications
PA 02-100 Complex Formation in Hormonal Regulation of Gene Expression
PA 02-094 Ancillary Studies on Control Groups in Clinical Trials
NIDDK Initiative Concepts for 2006
Development of Biomarkers for Disease
Animal Models of NIDDK-Relevant Diseases
Imaging Fibrosis in Kidney, Liver and Bladder
Potential Therapeutic Agents for Diseases of Protein Misprocessing or Misfolding
Genetic Longitudinal Studies of Obesity-Related Phenotypes
Translation of Invertebrate Obesity Genetics to Mammals
Planning or Implementation of New Clinical Studies of Interest to NIDDK
Obesity Research (from the NIH Point of View)NIH Obesity Taskforce established April, 200325 ICs and offices, co-chaired by the Directors of NIDDK and
NHLBIhttp://www.obesityresearch.nih.gov/
Strategic Plan: Research toward preventing and treating obesity through
lifestyle modification.
Research toward preventing and treating obesity through pharmacologic, surgical, or other medical approaches.
Research toward breaking the link between obesity and its associated health conditions.
Cross-cutting research topics, including health disparities, technology, fostering of interdisciplinary research teams, investigator training, translational research and education/outreach efforts.
NIDDK Office of Obesity Researchhttp://www.niddk.nih.gov/welcome/org/OD/OOR/OOR.htm
“Right hand” of NIH Obesity Task Forcecomprised of NIDDK staff
serves toassist the Director, NIDDK in identifying research opportunities, initiatives, and advances
identify and plan appropriate workshops and conferences
Clinical Trials in Obesity
Action to Control Cardiovascular Disease Risk in Diabetes (ACCORD)test best ways to lower risk of heart disease and stroke in adults with type 2
diabetes
BARI 2Bypass Angioplasty Revascularization Investigation 2 DiabetesDetermine the best therapies for people with type 2 diabetes and heart
disease
Longitudinal Assessment of Bariatric Surgery (LABS)conducting coordinated clinical, epidemiological, and behavioral research in
the field of bariatric surgery
SEARCH for Diabetes in Youth Studydetermine the prevalence of diabetes in children in six areas of the U.S. and
help clarify trends in the development of diabetes in youth
TODAY (Treatment Options for type 2 Diabetes in Adolescents and Youth)
identify the best treatment of type 2 diabetes in children and teens
Clinical Samples for Obesity & Diabetes Researchers
NIDDK Central Repositories: Biosamples, Genetics, Data
Established to store biosamples and data collected in designated
NIDDK-funded clinical studies. Purpose is to expand the usefulness of these studies by allowing a
wider research community to access collected materials
RFA-DK-03-022 receipt: July 19, 2005
Ancillary Studies to Obesity-Related Clinical Trials
Current Obesity Research Solicitations
RFA-DK-05-0 receipt: February 24, 2005 Preventing Mitochondrial Oxidative Stress in Diabetes and Obesity
RFA-HL-04-022 receipt: February 16, 2005 Bioengineering Approaches to Energy Balance and Obesity(measure energy balance, food intake, activity, etc.)
PA-04-156 receipt:Feb 1, June 1, Oct 1Bioengineering Approaches to Energy Balance and Obesity (SBIR/STTR)
RFA-ES-04-003 receipt: Dec. 17, 2004 Obesity and the Built Environment
RFA-DK-03-018 receipt: March 17, 2005 Genetic Studies of Obesity-Related Traits in Model Organisms (Drosophila, C elegans, zebrafish)
Obesity Program Announcements
Basic Research PA-04-124: Studies of Energy Balance and Cancer in Humans
PA-04-098: Heterogeneity of Fat Depots: Underlying Basis & Association with Morbidity
PA-04-081: Proteomics: Diabetes, Obesity, and Endocrine, Digestive, Kidney, Urologic & Hematologic Diseases
PA-04-033: Diet Composition and Energy Balance
Clinical and Behavior Research
PA-04-092: Long-Term Weight Maintenance: Basic and Clinical Studies
PAR-03-009: Improving Diet and Physical Activity Assessment
PAR-04-082: Small Clinical Grants in Digestive Diseases, Nutrition and Obesity
PA-04-121: Understanding Mechanisms of Health Risk Behavior Change in Children & Adolescents
PAR-03-060: Planning Grants for Translational Research for the Prevention and Control of Diabetes
PA-02-153: Translational Research for the Prevention and Control of Diabetes
PA-02-159: Enhancing Adolescent Health Promotion Across Multiple High Risk Behaviors
PA-05-009: Research on the Economics of Diet, Activity, and Energy Balance
PA-04-145: School-Based Interventions To Prevent Obesity
Obesity Program Announcements
Recent NIH Obesity Workshops
Women and ObesityNovember 4, 2004 1-3 p.m.
Obesity and the Built Environment: Improving Public Health Through Community Design May 24-26, 2004
Lipids and the Pathophysiology of Obesity May 10-11, 2004
From clinical trials to community: The science of translating diabetes and obesity researchJanuary 12-13, 2004
Adipose Tissue Secretory Function and Its Role in Obesity-Associated Co-Morbidities December 11-13, 2003
Phenotyping Obesity for Human Genetic Studies October 28-30, 2003
NIH Roadmap*(*from the NIH Point of View) Theory
NIH institutes working together to serve the unique needs of 21st century American biomedical science
PracticeResearch themes, projects and resources that no one
institute could support because of limited budgets and defined missions
28 initiatives & 171 awards to date Resources
$237M in FY05, projected to ~ $500M by FY09
The NIH Roadmap and ObesityPI: JAY D. HORTON Title: Task force for Obesity Research at UT SouthwesternRFA: Exploratory Centers for Interdisciplinary Research
Goals: Taskforce combines neuroendocrinology, genetics, lipid
metabolism, intermediary metabolism, and clinical epidemiology
Brain regulation of food intake and energy expenditure
Dysregulation of glucose and lipid metabolism in the liver
PI: BARRY M. POPKINProject Title: An Interdisciplinary Strategy for ObesityRFA: Exploratory Centers for Interdisciplinary Research
Goals: Inter-Disciplinary Obesity Center (IDOC)
Nutrition, epidemiology, health behavior, urban planning, health economics, physiology, psychology, genetics, and clinical medicine
Find effective interventions for prevention and treatment of obesity
The NIH Roadmap and Obesity
The NIH Roadmap & Metabolic DiseasePI: HENRI BRUNENGRABERTitle: Dynamic Metabolomics via Isotopomer AnalysisRFA: Metabolomics Technologies Development
Goals: Identify, measure and interpret the complex time-related
concentration, activity and flux of endogenous metabolites
instrumentation to increase sensitivity
Carbon-labeled substrates and 2H2O to measure fluxes in metabolic networks via mass isotopomer analysis
Models and multivariate statistics to provide new avenues for understanding metabolic diseases
NIH Roadmap Themes (& 13 Implementation Committees)New Pathways to Discovery
Building Blocks, Biological Pathways, and Networks Molecular Libraries & Molecular Imaging Structural Biology Bioinformatics and Computational Biology Nanomedicine
Research Teams of the FutureHigh-Risk Research Interdisciplinary Research Public-Private Partnerships
Re-engineering the Clinical Research EnterpriseClinical Research Networks/NECTAR Clinical Research Policy Analysis and Coordination Clinical Research Workforce TrainingDynamic Assessment of Patient-Reported Chronic Disease Outcomes Translational Research
New Pathways to Discovery Projects
SMALL MOLECULES Metabolomics Technology Development Projects
tools to measure metabolites and their dynamic fluctuations within cells
Molecular Libraries Screening Center Network (MLSCN) high throughput screening of chemically diverse small molecules (500,000) with the hope of providing new reagents for research (activators / inhibitors / markers)
MOLECULAR IMAGINGtechnologies and reagents for imaging of molecules or molecular events within single cells and whole organisms
PROTEINS National Technology Centers for Networks and Pathways
tools to measure the activity, translocation, and interactions of intracellular protein molecules
Innovation in Membrane Protein ProductionCenters to prepare membrane proteins for structural studies
Research Teams of the Future ProjectsHIGH RISK RESEARCH:
9 Pioneer Awards $500K/yr for 5 yrs to encourage creative, outside-the-box thinkers to pursue exciting and innovative ideas in biomedical research
INTERDISCIPLINARY RESEARCH Exploratory Centers (P20) for Interdisciplinary
Research Large series of training initiatives in IR
TRANSLATIONAL RESEARCHRAID: Rapid Access to Intervention Developmentresources for pre-clinical development of drugs (toxicology, dosing, manufacture, etc.)
2005 RM Initiatives (from 16 total) http://nihroadmap.nih.gov/grants/index.asp
Building Blocks, Biological Pathways RM-04-019 receipt 2/22/05 National Technology Centers for Networks and Pathways
Molecular Libraries
RM-04-027 receipt 3/10/05 Cheminformatics Research Centers
RM-05-011 receipt 2/14/05 Assay Technology Development
RM-05-014 receipt 2/15/05 Pilot-Scale Libraries for High-Throughput Screening
Structural Biology RM-04-026 receipt 1/24/05 Membrane Protein Production and Structure Determination
2005 RM Initiatives (cont’d.) http://nihroadmap.nih.gov/grants/index.asp
Interdisciplinary ResearchRM-04-008 receipt 2/11/05 Short Programs for Interdisciplinary Research Training
RM-05-010 receipt 2/11/05 Interdisciplinary Health Research Training: Behavior, Environment and Biology
High Risk ResearchNIH Director's Pioneer Awards
Other Funding Mechanisms for Partnerships BRP Bioengineering Research Partnerships
http://grants2.nih.gov/grants/guide/pa-files/PAR-04-023.html
R24 Interactive Partnerships NIGMS or NIDDK Grantees, Collaboration between funded investigators $300K/yr for 4 yrs, non-renewable For consortium activities http://grants2.nih.gov/grants/guide/pa-files/PA-
03-127.html
Contact Information
Maren R. Laughlin, Ph.D.Senior Advisor for Integrative MetabolismNIDDK, NIH6707 Democracy Blvd., MSC 5460Bethesda, MD 20892
www.nih.gov & www.niddk.nih.gov